SEC Form 4 · accession 0001162194-17-000085
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Evan/ Fa Jones
Director
Period of report
Jul 31, 2017
Accepted (ET)
Aug 2, 2017 · 8:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2017 | M | 5,000 | $0.00 | A | 58,551 | I | By jVen Capital, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | — | Jul 31, 2017 | M | 5,000 | D | Jul 31, 2017 | Jul 31, 2017 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1The reporting person is managing member of jVen Capital, LLC.
- F2Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.